The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

At Morgan Stanley, the new class is the first set of MD promotions under chief executive Ted Pick, who took the helm of the ...

LPL also drew from Osaic again, RIA aggregators made some big M&A deals and Merrill rehired an executive who left to go to ...

Investing.com -- Hermes shares are edging up, rebounding from intraday lows after Morgan Stanley (NYSE: MS) highlighted the ...

Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...

Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...